Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation
- PMID: 8087864
- DOI: 10.1006/cimm.1994.1266
Induction of cAMP-dependent protein kinase (PKA) activity in T cells after stimulation of the prostaglandin E2 or the beta-adrenergic receptors: relationship between PKA activity and inhibition of anti-CD3 monoclonal antibody-induced T cell proliferation
Abstract
Recently, we have shown that T cells exposed to concentrations of prostaglandin E2 (PGE2) or the beta-adrenergic receptor agonist isoproterenol (ISO) that elicit equimolar levels of cAMP accumulation do not inhibit anti-CD3 monoclonal antibody-induced T cell proliferation to the same extent. This report extends these studies by investigating the induction of cAMP-dependent protein kinase (PKA) in T cells stimulated with PGE2 or ISO. The kinetics of PKA activity induced by PGE2 or ISO in T cells are similar but PGE2 induces more PKA activity. When T cells were treated with concentrations of PGE2 or ISO that elicited similar PKA activities, PGE2 was found to be more immunosuppressive than ISO. T cells stimulated with PGE2 or ISO showed similar levels of increased PKA activity in both the cytosolic and the particulate fractions. Quantitation of the activity of PKA I and PKA II isozymes in T cells stimulated with PGE2 or ISO revealed that both types were activated; however, while PGE2 induced the utilization of an equal amount of both isozymes in T cells, ISO-treated cells utilized twice as much PKA I compared to PKA II. Overall, these results suggest that qualitative differences in the concentration of cAMP and PKA activity are important elements in modulatory T cell proliferative responses.
Similar articles
-
Modulation of T cell proliferation by stimulation of the beta-adrenergic receptor: lack of correlation between inhibition of T cell proliferation and cAMP accumulation.Cell Immunol. 1993 May;148(2):408-21. doi: 10.1006/cimm.1993.1122. Cell Immunol. 1993. PMID: 8388322
-
Costimulatory signals modulate the antiproliferative effects of agents that elevate cAMP in T cells.Cell Immunol. 1994 Oct 1;158(1):116-30. doi: 10.1006/cimm.1994.1261. Cell Immunol. 1994. PMID: 8087859
-
beta-Agonist enhances type 2 T-cell survival and accumulation.J Allergy Clin Immunol. 2007 Jan;119(1):235-44. doi: 10.1016/j.jaci.2006.09.019. Epub 2006 Oct 23. J Allergy Clin Immunol. 2007. PMID: 17208607
-
Dopamine D2 receptor signaling via the arachidonic acid cascade: modulation by cAMP-dependent protein kinase A and prostaglandin E2.J Lipid Mediat. 1993 Mar-Apr;6(1-3):433-43. J Lipid Mediat. 1993. PMID: 8395253 Review.
-
Protein kinase A: regulation and receptor-mediated delivery of antisense oligonucleotides and cytotoxic drugs.Ann N Y Acad Sci. 2002 Jun;968:158-72. doi: 10.1111/j.1749-6632.2002.tb04334.x. Ann N Y Acad Sci. 2002. PMID: 12119275 Review.
Cited by
-
Role of Ca2+ in prostaglandin E2-induced T-lymphocyte proliferative suppression in sepsis.Infect Immun. 1995 Aug;63(8):3101-5. doi: 10.1128/iai.63.8.3101-3105.1995. Infect Immun. 1995. PMID: 7622237 Free PMC article.
-
Harnessing prostaglandin E2 signaling to ameliorate autoimmunity.Trends Immunol. 2023 Mar;44(3):162-171. doi: 10.1016/j.it.2023.01.004. Epub 2023 Jan 25. Trends Immunol. 2023. PMID: 36707339 Free PMC article. Review.
-
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells.Blood. 2006 Mar 1;107(5):2052-60. doi: 10.1182/blood-2005-08-3265. Epub 2005 Nov 8. Blood. 2006. PMID: 16278302 Free PMC article.
-
Regulation of T cells in airway disease by beta-agonist.Front Biosci (Schol Ed). 2010 Jun 1;2(3):969-79. doi: 10.2741/s113. Front Biosci (Schol Ed). 2010. PMID: 20515836 Free PMC article. Review.
-
Sympathetic modulation of immunity: relevance to disease.Cell Immunol. 2008 Mar-Apr;252(1-2):27-56. doi: 10.1016/j.cellimm.2007.09.005. Epub 2008 Mar 4. Cell Immunol. 2008. PMID: 18308299 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources